Semin Oncol. 2011 Dec;38(6):776-80.

Clinical implications of microRNAs in lung cancer.

Fanini F, Vannini I, Amadori D, Fabbri M.

Source

Gene Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

Abstract

Lung cancer still represents a very deadly disease in strong need of new, effective, therapeutic approaches. MicroRNAs (miRNAs) represent a new category of noncoding RNAs with gene expression regulatory functions. Several studies have shown that miRNAs are frequently deregulated in lung cancer patients with respect to healthy individuals. These aberrations of the miRNome (defined as the full spectrum of miRNAs in a given genome) occur at several levels, including primary tumors and patient body fluids (such as blood and sputum), suggesting that miRNAs can be effectively used as biological markers with diagnostic, prognostic, and predictive implications. This review focuses on these translational aspects of research on the field of miRNAs and lung cancer.

PMID:: 22082763; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Lung Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Involvement of microRNAs in lung cancer biology and therapy. [Transl Res. 2011]
Review Involvement of microRNAs in lung cancer biology and therapy.
Liu X, Sempere LF, Guo Y, Korc M, Kauppinen S, Freemantle SJ, Dmitrovsky E. Transl Res. 2011 Apr; 157(4):200-8. Epub 2011 Feb 4.
Review [MicroRNAs in diagnosis and prognosis in lung cancer]. [Rev Invest Clin. 2011]
Review [MicroRNAs in diagnosis and prognosis in lung cancer].
Avila-Moreno F, Urrea F, Ortiz-Quintero B. Rev Invest Clin. 2011 Sep-Oct; 63(5):516-35.
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. [Lung Cancer. 2010]
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.
Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. Lung Cancer. 2010 Feb; 67(2):170-6. Epub 2009 May 14.
Review MicroRNAs in body fluids--the mix of hormones and biomarkers. [Nat Rev Clin Oncol. 2011]
Review MicroRNAs in body fluids--the mix of hormones and biomarkers.
Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. Nat Rev Clin Oncol. 2011 Jun 7; 8(8):467-77. Epub 2011 Jun 7.
Review MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment. [Exp Biol Med (Maywood). 2012]
Review MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Wang Q, Wang S, Wang H, Li P, Ma Z. Exp Biol Med (Maywood). 2012 Mar 1; 237(3):227-35. Epub 2012 Feb 16.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Clinical implications of microRNAs in lung cancer.
Clinical implications of microRNAs in lung cancer.
Semin Oncol. 2011 Dec ;38(6):776-80.

PubMed
MicroRNAs: toward the clinic for breast cancer patients.
MicroRNAs: toward the clinic for breast cancer patients.
Semin Oncol. 2011 Dec ;38(6):764-75.

PubMed
Alterations of microRNAs contribute to colon carcinogenesis.
Alterations of microRNAs contribute to colon carcinogenesis.
Semin Oncol. 2011 Dec ;38(6):734-42.

PubMed
Factors affecting patients' pain intensity during in office intravitreal injecti...
Factors affecting patients' pain intensity during in office intravitreal injection procedure.
Retina. 2012 Apr ;32(4):696-700.

PubMed
Minimally invasive approaches to the cervical spine.
Minimally invasive approaches to the cervical spine.
Orthop Clin North Am. 2012 Jan ;43(1):137-47, x. Epub 2011 Oct 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: